NCT02609685View on ClinicalTrials.gov

Active Surveillance of Papillary Thyroid Microcarcinoma

NARecruitingINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

May 13, 2016

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Papillary Thyroid Microcarcinoma
Interventions
OTHER

Active Surveillance

Subjects will be actively observed for disease progression (condition worsens) instead of receiving immediate surgery, considered standard of care.

Trial Locations (1)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER